Sfoglia per Autore
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients
2017-01-01 Rigo, F; Cucchetto, G; Lanzafame, Massimiliano; Nicolè, S; Lattuada, Emanuela; Concia, Ercole; Vento, Sandro
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
2017-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Nicole', Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir
2018-01-01 Lanzafame, M; Nicole, S; Rizzardo, S; Piacentini, D; Chiesi, S; Lattuada, E; Diani, E; Carelli, M; Vento, S; Gibellini, D
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials
2018-01-01 Nicole', Stefano; Lanzafame, M; Cucchetto, Giulia; Rigo, F; Lattuada, E; Concia, E
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life
2018-01-01 Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report
2019-01-01 Chiesi, Sheila; Rizzardo, Sebastiano; Piacentini, Daniela; Be, Giorgia; Lattuada, Emanuela; Tacconelli, Evelina; Lanzafame, Massimiliano
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study
2019-01-01 Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Bragantini, Damiano; Nicolè, Stefano; Calza, Leonardo; Tacconelli, Evelina
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients
2019-01-01 Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vincenzi, Marcello; Tacconelli, Evelina; Vento, Sandro
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients
2019-01-01 Nicolè, Stefano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vecchi, Marta; Tacconelli, Evelina; Vento, Sandro
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART
2019-01-01 DALLA GRANA, Elisa; Rigo, Fabio; Lanzafame, Massimiliano; Lattuada, Emanuela; Suardi, Silvia; Mottes, Monica; Valenti, Maria Teresa; Dalle Carbonare, Luca
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor
2020-01-01 Piacentini, Daniela; Lanzafame, Massimiliano; Rizzardo, Sebastiano; Chiesi, Sheila; Lattuada, Emanuela; Mehrabi, Sara; Zamboni, Giulia; Mazzi, Romualdo; Tacconelli, Evelina; Vento, Sandro
'High' antiretroviral deintensification strategy and cellular HIV DNA levels
2020-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Vincenzi, Marcello; Vecchi, Marta; Luise, Dora; Diani, Erica; Gibellini, Davide
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients
2021-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Gottardo, Rossella; Piacentini, Daniela; Be, Giorgia; Razzaboni, Elisa; Cattaneo, Paolo; Luise, Dora; Vento, Sandro
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy
2022-01-01 Luise, Dora; Lattuada, Emanuela; Rizzardo, Sebastiano; Nicol(`(e)), Stefano; Lambertenghi, Lorenza; Coledan, Ilaria; Gambino, Silvia; Gottardo, Rossella; Lanzafame, Massimiliano; Vento, Sandro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients | 1-gen-2017 | Rigo, F; Cucchetto, G; Lanzafame, Massimiliano; Nicolè, S; Lattuada, Emanuela; Concia, Ercole; Vento, Sandro | |
| Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient | 1-gen-2017 | Lanzafame, Massimiliano; Lattuada, Emanuela; Nicole', Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro | |
| Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir | 1-gen-2018 | Lanzafame, M; Nicole, S; Rizzardo, S; Piacentini, D; Chiesi, S; Lattuada, E; Diani, E; Carelli, M; Vento, S; Gibellini, D | |
| Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials | 1-gen-2018 | Nicole', Stefano; Lanzafame, M; Cucchetto, Giulia; Rigo, F; Lattuada, E; Concia, E | |
| Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life | 1-gen-2018 | Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro | |
| Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report | 1-gen-2019 | Chiesi, Sheila; Rizzardo, Sebastiano; Piacentini, Daniela; Be, Giorgia; Lattuada, Emanuela; Tacconelli, Evelina; Lanzafame, Massimiliano | |
| Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study | 1-gen-2019 | Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Bragantini, Damiano; Nicolè, Stefano; Calza, Leonardo; Tacconelli, Evelina | |
| Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients | 1-gen-2019 | Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vincenzi, Marcello; Tacconelli, Evelina; Vento, Sandro | |
| Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients | 1-gen-2019 | Nicolè, Stefano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vecchi, Marta; Tacconelli, Evelina; Vento, Sandro | |
| Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART | 1-gen-2019 | DALLA GRANA, Elisa; Rigo, Fabio; Lanzafame, Massimiliano; Lattuada, Emanuela; Suardi, Silvia; Mottes, Monica; Valenti, Maria Teresa; Dalle Carbonare, Luca | |
| Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor | 1-gen-2020 | Piacentini, Daniela; Lanzafame, Massimiliano; Rizzardo, Sebastiano; Chiesi, Sheila; Lattuada, Emanuela; Mehrabi, Sara; Zamboni, Giulia; Mazzi, Romualdo; Tacconelli, Evelina; Vento, Sandro | |
| 'High' antiretroviral deintensification strategy and cellular HIV DNA levels | 1-gen-2020 | Lanzafame, Massimiliano; Lattuada, Emanuela; Vincenzi, Marcello; Vecchi, Marta; Luise, Dora; Diani, Erica; Gibellini, Davide | |
| Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients | 1-gen-2021 | Lanzafame, Massimiliano; Lattuada, Emanuela; Gottardo, Rossella; Piacentini, Daniela; Be, Giorgia; Razzaboni, Elisa; Cattaneo, Paolo; Luise, Dora; Vento, Sandro | |
| Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy | 1-gen-2022 | Luise, Dora; Lattuada, Emanuela; Rizzardo, Sebastiano; Nicol(`(e)), Stefano; Lambertenghi, Lorenza; Coledan, Ilaria; Gambino, Silvia; Gottardo, Rossella; Lanzafame, Massimiliano; Vento, Sandro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile